Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Contineum Therapeutics, Inc. - Common stock
(NQ:
CTNM
)
20.06
+1.82 (+9.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
43,944
Open
18.56
Bid (Size)
19.68 (1)
Ask (Size)
24.59 (1)
Prev. Close
18.24
Today's Range
18.56 - 20.06
52wk Range
13.27 - 22.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CTNM Stock Earnings: Contineum Therapeutics Misses EPS for Q2 2024
August 13, 2024
CTNM stock results show that Contineum Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 13, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Performance
YTD
+30.26%
+30.26%
1 Month
-4.70%
-4.70%
3 Month
+36.46%
+36.46%
6 Month
+30.26%
+30.26%
1 Year
+30.26%
+30.26%
More News
Read More
Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis
July 31, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
June 24, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
June 04, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
June 03, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
May 20, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 16, 2024
From
Contineum Therapeutics, Inc.
Via
Business Wire
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Via
Benzinga
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
April 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.